Key result
Complete excision of conjunctival myxoma yields 0% recurrence, underscoring links to Carney complex.
Why the study?
Conjunctival myxoma is an exceptionally rare ocular tumor with limited clinical characterization and potential association with Carney complex.
Supports conservative excision for suspected conjunctival myxoma; leaves open need for prospective data on recurrence.
Conjunctival myxoma is an exceptionally rare, slow-growing, benign neoplasm of primitive mesenchyme origin. Forty-one cases of conjunctival myxoma from a literature review, including the authors' case, are listed. The usual clinical history is a painless mass appearing during months to years. Grossly, the tumor is a well-circumscribed, cystlike, gelatinous, yellow-to-pink, translucent-to-solid mass. Microscopically, the hypocellular tumor contains stellate- and spindle-shaped cells in a mucoid stroma with abundant hyaluronic acid mucopolysaccharides. Vimentin and α-smooth muscle actin highlight the spindle and stellate cells. S100 protein and desmin are negative for the tumor cells. Treatment is complete surgical excision, with no recurrence reported in the follow-up period. Notably, conjunctival myxoma may be associated with Carney complex, an autosomal-dominant disorder associated with skin pigmentation, endocrine abnormalities, and myxoma of the heart and eye. Physicians should appreciate this unique ocular tumor because of its potential association with Carney complex.
No takes yet. Share an insight, caveat, or question.
Xiong et al. (2015) conducted a review in Conjunctival myxoma (n=41). Complete surgical excision was evaluated on Tumor recurrence. A literature review of 41 cases of conjunctival myxoma found that complete surgical excision resulted in 0 reported recurrences, highlighting its potential association with Carney complex.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: